Argentina Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook

The clinical trial biorepository & archiving solutions market in Argentina is expected to reach a projected revenue of US$ 38.6 million by 2030. A compound annual growth rate of 10.2% is expected of Argentina clinical trial biorepository & archiving solutions market from 2024 to 2030.
Revenue, 2023 (US$M)
$19.6
Forecast, 2030 (US$M)
$38.6
CAGR, 2024 - 2030
10.2%
Report Coverage
Argentina

Argentina clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)

Argentina

Related Markets

Argentina clinical trial biorepository & archiving solutions market highlights

  • The Argentina clinical trial biorepository & archiving solutions market generated a revenue of USD 19.6 million in 2023 and is expected to reach USD 38.6 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
  • In terms of segment, biorepository services was the largest revenue generating service in 2023.
  • Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.


Clinical trial biorepository & archiving solutions market data book summary

Market revenue in 2023USD 19.6 million
Market revenue in 2030USD 38.6 million
Growth rate10.2% (CAGR from 2023 to 2030)
Largest segmentBiorepository services
Fastest growing segmentBiorepository Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiorepository Services, Archiving Solution Services
Key market players worldwideAzenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the global clinical trial biorepository & archiving solutions market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 82.5 million by 2030.

Biorepository services was the largest segment with a revenue share of 66.33% in 2023. Horizon Databook has segmented the Argentina clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.


Argentina represents an attractive option for pharmaceutical companies to conduct clinical trials. Presence of well-trained healthcare professionals, a vast network of medical establishments, and relatively low cost of conducting clinical trials in the country in comparison with European & Asian countries are expected to drive market growth. In addition, recruitment of patients for clinical trial studies is easier in Argentina, thus covering a large patient pool in the study.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Biorepository & Archiving Solutions Market Companies

Name Profile # Employees HQ Website

Argentina clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)

Argentina Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)

Argentina clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more